Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

201 projects found matching your search criteria :

  1. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  2. Neuroplasticity regulation by alternative gene transcription

    Call: SONATA 2 , Panel: NZ3

    Principal investigator: dr Michał Korostyński

    Instytut Farmakologii PAN

  3. The molecular basis of stress-induced anxiety and affective disorders

    Call: OPUS 2 , Panel: NZ2

    Principal investigator: dr Michał Korostyński

    Instytut Farmakologii PAN

  4. Glucocorticoid-induced alterations of astrocytic metabolism in stress-related disorders.

    Call: OPUS 2 , Panel: NZ3

    Principal investigator: dr Michał Wiesław Ślęzak

    Instytut Farmakologii PAN

  5. The influence of molecular fingerprint bit density on chemical pattern recognition effectiveness

    Call: PRELUDIUM 2 , Panel: NZ2

    Principal investigator: Rafał Jerzy Kurczab

    Instytut Farmakologii PAN

  6. The role of astrocytes and cellular metabolism in functional compensation of degeneration of dopaminergic system in the ...

    Call: OPUS 3 , Panel: NZ4

    Principal investigator: dr Katarzyna Kuter

    Instytut Farmakologii PAN

  7. Neurobiological basis of sensation seeking behaviour

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: Magdalena Maria Sikora

    Instytut Farmakologii PAN

  8. Effects of prenatal stress on properities of neurons and synaptic transmission in dorsal raphe nucleus of the rat

    Call: PRELUDIUM 9 , Panel: NZ4

    Principal investigator: Joanna Grażyna Sowa

    Instytut Farmakologii PAN

  9. Molecular mechanism of interactions between GPCRs and G protein.

    Call: PRELUDIUM 10 , Panel: NZ2

    Principal investigator: Stefan Mateusz Mordalski

    Instytut Farmakologii PAN

  10. Development of protocol for in silico design of compounds inhibit Ebola virus infection

    Call: PRELUDIUM 11 , Panel: NZ2

    Principal investigator: Dawid Zdzisław Warszycki

    Instytut Farmakologii PAN

  11. Pharmacological properties and neurotoxicity of novel NBOMe derivatives

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Krystyna Czesława Gołembiowska

    Instytut Farmakologii PAN

  12. The role of the endogenuous opioid system in prosocial behavior

    Call: OPUS 11 , Panel: NZ4

    Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii PAN

  13. The effect of chronic treatment with iasenapine and iloperidone on the expression and activity of cytochrome P450 in the...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Przemysław Jan Danek

    Instytut Farmakologii PAN

  14. Effects of a novel nonaddictive opioid on response to stress

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: dr Łucja Elżbieta Szumiec

    Instytut Farmakologii PAN

  15. Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Katarzyna Popiołek-Barczyk

    Instytut Farmakologii PAN

  16. Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Justyna Beata Barut

    Instytut Farmakologii PAN

  17. Effects of ketamine optical isomers on motivation and decision-making in rats using deep learning for behavioral analysi...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Natalia Alicja Malikowska-Racia

    Instytut Farmakologii PAN

  18. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  19. Decoding the novel role of the histamine H3 receptor in opioid-induced analgesia and hyperalgesia: studies toward innova...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Katarzyna Popiołek-Barczyk

    Instytut Farmakologii PAN

  20. Investigation of novel functionally selective opioid receptors agonists

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Łucja Elżbieta Szumiec

    Instytut Farmakologii PAN

  21. Opioid receptors in the basal ganglia of the brain as targets for alcohol abuse therapy.

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii PAN

  22. The study of the role of mGluR8 in cancer cells - a potential target for new antitumor strategies

    Call: OPUS 3 , Panel: NZ3

    Principal investigator: dr Danuta Jantas

    Instytut Farmakologii PAN

  23. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Call: MAESTRO 3 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii PAN

  24. "Epigenetic mechanisms underlying cocaine seeking and relapse"

    Call: MAESTRO 3 , Panel: NZ3

    Principal investigator: prof. Małgorzata Maria Filip

    Instytut Farmakologii PAN

  25. PHARMACOTHERAPY OF OSTEOARTHRITIS: TRPV1 AND CB1 RECEPTORS AND THEIR ENDOGENOUS LIGANDS AS NEW TARGETS FOR PHARMACOLOGIC...

    Call: SONATA BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

  26. Neurobiology of optimism; Characterisation of the neuroanatomical and neurochemical substrates of cognitive judgement bi...

    Call: SONATA BIS 2 , Panel: NZ4

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii PAN

  27. The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr Agnieszka Wąsik

    Instytut Farmakologii PAN

  28. The effects of positive allosteric modulators of alpha7 nicotinic acetylcholine receptors on complex cognitive processes...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Nikiforuk

    Instytut Farmakologii PAN

  29. The effect of imipramine and risperidone on regulation of the chronic mild stress-induced anhedonia and memory impairmen...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: dr hab. Mariusz Papp

    Instytut Farmakologii PAN

  30. Motor thalamic nuclei as a potential therapeutic target for adenosine in parkinsonian and essential tremor; behavioural,...

    Call: OPUS 6 , Panel: NZ4

    Principal investigator: dr hab. Jadwiga Wardas

    Instytut Farmakologii PAN

  31. The effect of the novel atypical neuroleptics on the activity and expression of cytochrome P450 isoforms in human liver

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii PAN

  32. Research of mechanisms of antidepressant action of group II and III mGlu receptor ligands and their role in inducing rap...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

  33. Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment: study on the novel genet...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii PAN

  34. The impact of maternal diabetes on inflammasome NLRP3 activation in the offspring brain

    Call: PRELUDIUM 7 , Panel: NZ7

    Principal investigator: dr Katarzyna Elżbieta Głombik

    Instytut Farmakologii PAN

  35. The effect of social stress during adolescence on the psychotic symptoms development and epigenetic mechanisms in the ne...

    Call: OPUS 7 , Panel: NZ4

    Principal investigator: dr hab. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii PAN

  36. Spatial analysis of the effects of L-DOPA on gene expression in the prefrontal cortex in a mouse model of Parkinson's di...

    Call: PRELUDIUM 19 , Panel: NZ4

    Principal investigator: dr Anna Aleksandra Radlicka-Borysewska

    Instytut Farmakologii PAN

  37. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

  38. A premotor disease signature for ALS

    Call: JPco-fuND2 Call 2021 , Panel: NZ7

    Principal investigator: dr Wojciech Kuban

    Instytut Farmakologii PAN

  39. Brain GABAB receptors as determinants of obesity phenotypes: evaluation of adolescent female and male rats

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: prof. Małgorzata Maria Filip

    Instytut Farmakologii PAN

  40. Cognitive impairment in chronic pain - CBD as the undervalued remedy.

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

  41. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

  42. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

  43. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

    Instytut Farmakologii PAN

  44. Impact of maternal monosaccharide diet on dams and offspring hippocampus development.

    Call: PRELUDIUM 22 , Panel: NZ1

    Principal investigator: Kacper Karol Witek

    Instytut Farmakologii PAN

  45. The role of selected signaling pathways in zinc deficiency

    Call: OPUS 10 , Panel: NZ4

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  46. Neurodevelopmental patomechanisms of triclocarban- and dichlorodiphenyldichloroetylene-induced effects: the role of apop...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Kajta

    Instytut Farmakologii PAN

  47. Molecular characteristics of stress-resilient phenotype using mice models.

    Call: OPUS 12 , Panel: NZ4

    Principal investigator: prof. Marta Dziedzicka-Wasylewska

    Instytut Farmakologii PAN

  48. Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii PAN

  49. Zinc Deficiency: An essential Variable for the Induction od Resistance to Antidepressants

    Call: PRELUDIUM 13 , Panel: NZ5

    Principal investigator: dr Anna Maria Rafało-Ulińska

    Instytut Farmakologii PAN

  50. Modified maternal diet as a factor of autism spectrum disorders in offspring - preclinical molecular studies on prefront...

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: Kinga Eryka Gawlińska

    Instytut Farmakologii PAN

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy